NCT07631663 Satiety Evaluation of Mature Okra Flour-incorporated Biscuit
| NCT ID | NCT07631663 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universiti Putra Malaysia |
| Condition | Appetite Regulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-05-15 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate whether eating biscuits made with mature okra flour can help young adults feel fuller (enhance satiety) and change certain blood markers compared to eating standard biscuits. Mature okra is a nutrient-dense agricultural by-product that is often discarded due to its tough texture. For this study, mature okra pods are dried and ground into a flour, which is then used to replace 10% of the wheat flour in a custom biscuit formulation. Participants will take part in a single-blind, randomised trial where they will consume either the okra-incorporated biscuits or the standard control biscuits on separate occasions. Researchers will measure participants' perceived fullness over 165 minutes using a visual rating scale. Blood samples will also be collected at specific intervals during this time to evaluate blood glucose levels, appetite-related hormones, and metabolic responses.
Eligibility Criteria
Inclusion Criteria: * Young adults aged between 18 and 39 years. * Normal Body Mass Index (BMI). Exclusion Criteria: * Smokers. * Pregnant or lactating women. * Individuals with daily medication prescriptions for chronic metabolic conditions, cardiovascular management, or hormonal regulation. * Use of daily medications/supplements that influence appetite regulation, metabolic signalling, or systemic metabolomic profiles, including: 1. Hormonal contraceptives, glucocorticoids, and oral/injectable anti-obesity medications (e.g., GLP-1 agonists). 2. Antihypertensives and lipid-lowering agents (statins). 3. Chronic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). 4. Daily fibre supplements.
Contact & Investigator
Mohd Redzwan Sabran, PhD
STUDY CHAIR
Universiti Putra Malaysia
Frequently Asked Questions
Who can join the NCT07631663 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 39 Years, studying Appetite Regulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07631663 currently recruiting?
Yes, NCT07631663 is actively recruiting participants. Contact the research team at cheeyee721@gmail.com for enrollment information.
Where is the NCT07631663 trial being conducted?
This trial is being conducted at Serdang, Malaysia.
Who is sponsoring the NCT07631663 clinical trial?
NCT07631663 is sponsored by Universiti Putra Malaysia. The principal investigator is Mohd Redzwan Sabran, PhD at Universiti Putra Malaysia. The trial plans to enroll 30 participants.